These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17693092)

  • 21. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) -- structural investigations on two different carrier systems.
    Saupe A; Wissing SA; Lenk A; Schmidt C; Müller RH
    Biomed Mater Eng; 2005; 15(5):393-402. PubMed ID: 16179760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterisation of colloidal drug delivery systems from the naked eye to Cryo-FESEM.
    Krauel K; Girvan L; Hook S; Rades T
    Micron; 2007; 38(8):796-803. PubMed ID: 17698364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipid nanoparticles for improved topical application of drugs for skin diseases.
    Schäfer-Korting M; Mehnert W; Korting HC
    Adv Drug Deliv Rev; 2007 Jul; 59(6):427-43. PubMed ID: 17544165
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Preparation and liver targeting of floxuridinyl dibutyrate solid lipid nanoparticles].
    Li JJ; Yang GD; Wang HY; Zhang SQ
    Yao Xue Xue Bao; 2008 Jul; 43(7):761-5. PubMed ID: 18819483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Q10-loaded NLC versus nanoemulsions: stability, rheology and in vitro skin permeation.
    Junyaprasert VB; Teeranachaideekul V; Souto EB; Boonme P; Müller RH
    Int J Pharm; 2009 Jul; 377(1-2):207-14. PubMed ID: 19465098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction of lipid nanoparticles with human epidermis and an organotypic cell culture model.
    Kuntsche J; Bunjes H; Fahr A; Pappinen S; Rönkkö S; Suhonen M; Urtti A
    Int J Pharm; 2008 Apr; 354(1-2):180-95. PubMed ID: 17920216
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Visualizing the structure of triglyceride nanoparticles in different crystal modifications.
    Bunjes H; Steiniger F; Richter W
    Langmuir; 2007 Mar; 23(7):4005-11. PubMed ID: 17316032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Solid lipid nanoparticles (SLN) of tretinoin: potential in topical delivery.
    Shah KA; Date AA; Joshi MD; Patravale VB
    Int J Pharm; 2007 Dec; 345(1-2):163-71. PubMed ID: 17644288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Production & stability of stavudine solid lipid nanoparticles--from lab to industrial scale.
    Shegokar R; Singh KK; Müller RH
    Int J Pharm; 2011 Sep; 416(2):461-70. PubMed ID: 20727389
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Solid lipid nanoparticles prepared by solvent diffusion method in a nanoreactor system.
    Yuan H; Huang LF; Du YZ; Ying XY; You J; Hu FQ; Zeng S
    Colloids Surf B Biointerfaces; 2008 Feb; 61(2):132-7. PubMed ID: 17888636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy.
    Jores K; Mehnert W; Drechsler M; Bunjes H; Johann C; Mäder K
    J Control Release; 2004 Mar; 95(2):217-27. PubMed ID: 14980770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of surfactant properties on oxidative stability of beta-carotene encapsulated within solid lipid nanoparticles.
    Helgason T; Awad TS; Kristbergsson K; Decker EA; McClements DJ; Weiss J
    J Agric Food Chem; 2009 Sep; 57(17):8033-40. PubMed ID: 19691283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of SLNs from natural lipids: application to topical delivery of tretinoin.
    Mandawgade SD; Patravale VB
    Int J Pharm; 2008 Nov; 363(1-2):132-8. PubMed ID: 18657601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experimental factorial design applied to mucoadhesive lipid nanoparticles via multiple emulsion process.
    Fangueiro JF; Andreani T; Egea MA; Garcia ML; Souto SB; Souto EB
    Colloids Surf B Biointerfaces; 2012 Dec; 100():84-9. PubMed ID: 22766285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipid nanoparticles for alkyl lysophospholipid edelfosine encapsulation: development and in vitro characterization.
    Estella-Hermoso de Mendoza A; Rayo M; Mollinedo F; Blanco-Prieto MJ
    Eur J Pharm Biopharm; 2008 Feb; 68(2):207-13. PubMed ID: 17707618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dry hybrid lipid-silica microcapsules engineered from submicron lipid droplets and nanoparticles as a novel delivery system for poorly soluble drugs.
    Simovic S; Heard P; Hui H; Song Y; Peddie F; Davey AK; Lewis A; Rades T; Prestidge CA
    Mol Pharm; 2009; 6(3):861-72. PubMed ID: 19358600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The size of solid lipid nanoparticles: an interpretation from experimental design.
    Vitorino C; Carvalho FA; Almeida AJ; Sousa JJ; Pais AA
    Colloids Surf B Biointerfaces; 2011 May; 84(1):117-30. PubMed ID: 21242064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improvement of in vitro efficacy of a novel schistosomicidal drug by incorporation into nanoemulsions.
    de Araújo SC; de Mattos AC; Teixeira HF; Coelho PM; Nelson DL; de Oliveira MC
    Int J Pharm; 2007 Jun; 337(1-2):307-15. PubMed ID: 17292573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rheological and in vitro release behaviour of clotrimazole-containing aqueous SLN dispersions and commercial creams.
    Souto EB; Müller RH
    Pharmazie; 2007 Jul; 62(7):505-9. PubMed ID: 17718190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Solid lipid nanoparticles (SLN) for topical drug delivery: incorporation of the lipophilic drugs N,N-diethyl-m-toluamide and vitamin K.
    Işcan Y; Wissing SA; Hekimoğlu S; Müller RH
    Pharmazie; 2005 Dec; 60(12):905-9. PubMed ID: 16398266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.